As a result, KDM4B was identified as a gene that is variably but significantly highly expressed in AML cases associated with t(8;21) [hereafter referred to as t(8;21) AML]26 (Figure 1A). The gene discussed is KDM4B; the disease is acute myeloid leukemia.